IRDAI’s proposed commission curbs trigger sharp sell-off in PB Fintech

What to watch

• Publication of the final IRDAI wording, including commission caps, expense limits, product-level exemptions and implementation dates.
• Whether renewals, protection products, health insurance and online/direct distribution receive differentiated treatment.
• Management commentary from PB Fintech on insurer commission contracts, insurance revenue growth, customer-acquisition cost and EBITDA expectations.
• Insurer disclosures on new-business margins, expense ratios, distribution mix and planned premium repricing.
• Evidence of reduced insurer advertising, cashback or lead-generation spending across digital and bancassurance channels.
• Any IRDAI requirements for commission disclosure, suitability audits, call-record retention, claims-service standards or penalties for mis-selling.
• Premium changes and customer conversion/renewal rates after implementation, which will determine whether savings reach consumers.
• PB Fintech is likely to emphasize renewal revenue, cross-sell, higher-conversion customer cohorts and non-insurance products to offset lower commission yields.
• Insurers may renegotiate distributor contracts, shift marketing budgets toward owned channels and tighten underwriting or product eligibility to preserve profitability.
• Bancassurance partners may favor fewer insurer relationships and products with stronger embedded economics, increasing concentration among large insurers and banks.
• Digital distributors may introduce more explicit advisory, service or subscription fees where permitted, though consumer willingness to pay could be limited.
• Smaller brokers and agent networks with high acquisition costs may consolidate, exit low-ticket products or move toward insurer-sponsored models.
• Insurers could initially retain part of any commission savings rather than cut premiums, making consumer savings dependent on competitive intensity and regulatory enforcement.